ATRA Overview
Upcoming Projects (ATRA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ATRA)
-
Examining the potential of Atara's tabelecleucel (tab-cel), an immunotherapy for Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD) ahead of its Jan 10th FDA PDUFA
Ticker: ATRA
Executed On: Jan 07, 2026 at 04:00 PM EST -
Understanding the future of Allogeneic T cell therapy after the EU approval of Atara's Ebvallo
Ticker: ATRA
Executed On: Mar 14, 2023 at 05:00 PM EDT -
A look at pending data update from ATA188 and potential in multiple sclerosis.
Ticker: ATRA
Executed On: Apr 22, 2022 at 10:00 AM EDT
Upcoming & Overdue Catalysts (ATRA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ATRA)
Strategic Initiatives (ATRA)
